Faithward Advisors’s Merck MRK Stock Holding History

Faithward Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	9,623 +2,430	+34%	+$281K	0.17%	112
2025 Q4	$757K	Sell	7,193 -406	-5%	-$38.1K	0.11%	151
2025 Q3	$638K	Sell	7,599 -312	-4%	-$25.7K	0.09%	150
2025 Q2	$626K	Sell	7,911 -1,163	-13%	-$92.4K	0.1%	139
2025 Q1	$814K	Buy	9,074 +278	+3%	+$26K	0.14%	120
2024 Q4	$875K	Sell	8,796 -889	-9%	-$91.7K	0.15%	110
2024 Q3	$1.1M	Sell	9,685 -698	-7%	-$82.9K	0.19%	106
2024 Q2	$1.29M	Buy	10,383 +241	+2%	+$31K	0.23%	101
2024 Q1	$1.34M	Buy	10,142 +4,610	+83%	+$568K	0.24%	92
2023 Q4	$698K	Buy	5,532 +1,019	+23%	+$106K	0.15%	101
2023 Q3	$462K	Buy	4,513 +132	+3%	+$14.2K	0.11%	113
2023 Q2	$471K	Buy	4,381 +2,122	+94%	+$241K	0.11%	105
2023 Q1	$266K	Buy	+2,259	New	+$244K	0.06%	156

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Faithward Advisors's MRK Position: Q1 2026 in Review

Faithward Advisors increased its Merck (MRK) stake by 34% in Q1 2026, buying an estimated $281K and bringing the position to 9,623 shares worth $1.16M. The position accounts for 0.17% of the portfolio, ranked #112.

Faithward Advisors first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.34M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Faithward Advisors held 9,623 shares of Merck worth $1.16M as of Q1 2026.
Faithward Advisors bought 2,430 Merck shares in Q1 2026, an estimated $281K.
Merck made up 0.17% of Faithward Advisors's portfolio in Q1 2026, its #112 holding.
Faithward Advisors first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
Faithward Advisors's Merck position peaked at $1.34M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.